Zdrowie i gospodarka · 28/12/2011

FDA Releases Draft Guidance for 510(k) Program Evaluating Substantial Equivalence

The Food and Drug Administration (FDA) has released a draft guidance document outlining its review process for premarket notification (510(k)) submissions, including the Special and Abbreviated 510(k) programs, to provide a contemporary perspective on substantial equivalence evaluations.